-
Mashup Score: 1Home | GSK - 2 day(s) ago
At GSK, we unite science, technology and talent to get ahead of disease together
Source: www.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
Trial unblinded early at an interim analysis based on Independent Data Monitoring Committee recommendation
Source: www.gsk.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Trial unblinded early at an interim analysis based on Independent Data Monitoring Committee recommendation
Source: www.gsk.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Home | GSK - 2 month(s) ago
At GSK, we unite science, technology and talent to get ahead of disease together
Source: www.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 2‘We’re not a world of men – it's as simple as that’: how gender diversity in clinical trials improves health outcomes for women | GSK - 3 month(s) ago
Until recently, medicines and vaccines were mainly tested on men, which has had a detrimental effect on women’s health globally.
Source: www.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4‘You can’t be what you can’t see’: Why diversity in STEM is key to greater medical innovation | GSK - 3 month(s) ago
Teams of scientists with different perspectives, backgrounds and experiences are proven to perform better and to be more creative.
Source: www.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 62
Results from an interim analysis of the DREAMM-7 phase III head-to-head trial.
Source: www.gsk.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Home | GSK - 3 month(s) ago
At GSK, we unite science, technology and talent to get ahead of disease together
Source: www.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 1
Investing in prevention delivers better health outcomes for patients, is cost-effective, and boosts the economy
Source: www.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 2Partnering with GSK | GSK - 4 month(s) ago
We partner with scientific institutions, national health systems, academia and industry to develop vaccines and medicines
Source: www.gsk.comCategories: General Medicine News, PayerTweet
RT @GSK: News for #Investors and #Media Explore our Q1 2024 figures at a glance. https://t.co/lkwsGeRArj. $GSK https://t.co/LJv31r98sx